Expertise in

conditions

Gerd U. Auffarth

Heidelberg, BW, DE

Expertise in

conditions

Heidelberg, BW, DE

Overview

Gerd Auffarth practices practicing medicine in Heidelberg, Germany.

Auffarth is highly rated in 28 conditions, according to our data. Their clinical expertise encompasses Cataract, Astigmatism, Presbyopia, Cataract Removal, and Corneal Transplant.

They are actively involved in clinical research, co-authoring 446 peer reviewed articles and participating in 5 clinical trials.

Locations

Heidelberg, BW, Germany

Other Locations

Salem, BW, Germany

Frankfurt Am Main, HE, Germany

Ahaus, NW, Germany

Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL

Enrollment Status: Completed

Publish Date: November 21, 2025

Intervention Type: Device

Study Phase: Not Applicable

An Interventional, Open-label, Multicenter Phase I/IIa Clinical Trial to Investigate the Safety and Efficacy of Ascending Doses of Allogeneic ABCB5-positive Limbal Stem Cells (LSC2) for the Treatment of Limbal Stem Cell Deficiency (LSCD)

Enrollment Status: Unknown

Publish Date: October 07, 2022

Intervention Type: Biological

Study Phase: Phase 1/Phase 2

A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004%

Enrollment Status: Completed

Publish Date: September 08, 2022

Intervention Type: Device, Drug

Study Drug: Travoprost

Study Phase: Phase 4

Development of a Database (Register) for Quality Assurance and Optimization of the Postoperative Results of Premium Intraocular Lenses

Enrollment Status: Completed

Publish Date: January 11, 2022

Intervention Type: Device

Study Phase: Not Applicable

Clinical Evaluation of the FluidVision Accommodating Intraocular Lens

Enrollment Status: Completed

Publish Date: May 21, 2021

Intervention Type: Procedure, Device

Study Phase: Not Applicable

View 4 Less Clinical Trials

446 Total Publications

Straylight-Based Evaluation of Glare in Two Presbyopia-Correcting Intraocular Lenses.

Journal: Klinische Monatsblatter fur Augenheilkunde

Published: August 14, 2026

View All 446 Publications

Frequently Asked Questions about Gerd U. Auffarth

Is Gerd U. Auffarth a top-rated expert for Cataract?

MediFind is an objective health platform that identifies experts based on real-world data. Gerd U. Auffarth is classified as an Elite expert for Cataract, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gerd U. Auffarth participate in research or clinical trials?

Yes. Gerd U. Auffarth has published 446 articles and abstracts on conditions like Cataract. You can view a list of Gerd U. Auffarth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Auffarth's expertise for a condition

ConditionClose